Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free: https://www.ghostery.com/fr/products/

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site: http://www.youronlinechoices.com/fr/controler-ses-cookies/, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Realytics
Google Analytics
Spoteffects
Optimizely

Targeted advertising cookies

DoubleClick
Mediarithmics

The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRAE’s Data Protection Officer by email at cil-dpo@inra.fr or by post at:

INRAE
24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Letizia DE CHIARA

Junior PI

University of Florence, Italy

Dr. Letizia De Chiara is a junior PI at the University of Florence, Italy. She obtained her PhD at the Molecular Biotechnology Center of Turin, Italy where she investigated the utility of novel stem cell therapies for the treatment of Acute Kidney Injury (AKI) and prevention of progression to Chronic Kidney Disease (CKD). Following the completion of her PhD studies, she moved to University College Dublin (UCD), Ireland and then she joined the Weill Cornell Medical College of New York, USA to pursue her studies on stem cell plasticity and kidney injury. In 2019, she was awarded a Marie Sklodowska-Curie Reintegration Fellowship to return to Italy in the lab of Prof. Paola Romagnani. Since then, her research has focused on investigating the link between AKI and CKD development. Recently, she was awarded a L’Oreal-UNESCO for Women in Science Award for her studies on developing new prognostic markers to stratify patients at risk of progressing toward CKD following AKI. She is currently part of the Kidney International editorial board and she is part of the second cohort of the International Society of Nephrology emerging leaders.